Farmacogenética y trastornos mentales

  • Ignacio Jáuregui-Lobera Instituto de Ciencias de la Conducta y Universidad Pablo de Olavide. Sevilla. España

Resumen

-

Descargas

La descarga de datos todavía no está disponible.

Citas

McCarthy AD, Kennedy JL, Middleton LT. Pharmacogenetics in drug development. Philos Trans R Soc Lond B Biol Sci. 2005;360:1579-1588.

Lesko LJ, Salerno RA, Spear BB, Anderson DC, Anderson T, Brazell C, et al. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: Report of the first FDA-PWG-PhRMA- Dru Safe Workshop. J Clin Pharmacol. 2003;43:342-358.

Butler MG. Pharmacogenetics and psychiatric care: A review and commentary. J Ment Health Clin Psychol. 2018; 2:17-24.

Pirmohamed M. Pharmacogenetics: past, present and future. Drug Discov Today. 2011;16: 852-861.

Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, et al. Efficacy of prospective pharmacogenetic testing in the treatment of major depression disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry. 2017;17:250.

Hamilton SP. The promise of psychiatric pharmacogenomics. Biol Psychiatry. 2015; 77:29-35.

Spadaler J, Tuson M, López-Ibor JM, López-Ibor F, López-Ibor MI. Pharmacogenetic testing of the guidance of Psychiatric treatment: A multicenter retrospective analysis. CNS Spectr. 2016;21:1-10.

Publicado
2020-07-01
Sección
Editorial